Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany

The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant effect of the new medicines compared to an appropriate comparator as defined by the Federal...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabisch, Inna, Dethling, Jürgen, Dintsios, Charalabos-Markos, Drechsler, Melanie, Kalanovic, Daniel, Kaskel, Peter, Langer, Frank, Ruof, Jörg, Ruppert, Thorsten, Wirth, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901346/
https://www.ncbi.nlm.nih.gov/pubmed/24460706
http://dx.doi.org/10.1186/2191-1991-4-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901346/
https://www.ncbi.nlm.nih.gov/pubmed/24460706
http://dx.doi.org/10.1186/2191-1991-4-2

Ejemplares similares